Key facts, as of
As of October 11, 2026, UnitedHealth Group (UNH) trades at $379.30, up 3.2% over the past year. Its 52-week range runs from $255.97 to $461.62; the price is 17.8% below that high. It is 39.9% below its all-time high of $630.73, reached in November 2024. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +209.7%, against +312.9% for the S&P 500 (SPY). It sits 6.1% above its 200-day average of $357.53, the usual sign of a long-term uptrend. Its 30-day volatility is 19.9% annualized, which we rate medium risk. It has a trailing P/E of 24.4 and a dividend yield of 2.45%.
Cite: Portfolio Terminal, "UnitedHealth Group (UNH) stock analysis", 2026-10-11. https://portfolio-terminal.com/analyse/unh
Where it trades today
trading 60% of the way up its 52-week range
How the price has moved
How far it is from its record
UnitedHealth Group (UNH) is 39.9% below its all-time high of $630.73, reached in November 2024. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +209.7%, against +312.9% for the S&P 500 (SPY).
What to weigh before acting
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- UNH is valued near its sector range at 24.4x earnings versus 22.0x for peers, so the next move likely needs a real earnings or guidance catalyst.
- UNH carries a beta of 0.61, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- Relative performance versus JNJ, PFE, ABBV matters here because leadership inside healthcare rarely stays static for long.
Portfolio Use Case
- UNH is more relevant for investors who want some income support alongside price appreciation, not just pure growth exposure.
- The beta profile suggests it can fit a quality or lower-volatility sleeve more naturally than a high-octane tactical basket.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- A reset in earnings expectations or a faster peer catch-up could compress the premium valuation currently embedded in UNH.
- The view would need revisiting if peers such as JNJ, PFE, ABBV start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for UNH come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as JNJ, PFE, ABBV.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for UNH. Last refresh: Oct 11, 2026, 11:03 PM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as JNJ, PFE, ABBV.
What UnitedHealth Group does
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations.…
Employees
390,000
Industry
Healthcare Plans
Headquarters
Eden Prairie, United States
What analysts expect
UNH carries a buy consensus from 25 analysts, with an average price target of $480.60 versus $379.30 today (+26.7%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
UNH generated $450.53B in trailing revenue (0.4% year over year), with a 3.1% net margin, and $24.27B of free cash flow, against $41.86B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $447.57B | $82.92B | $18.96B | $12.06B | $13.31 | $16.07B |
| 2024 | $400.28B | $89.40B | $32.29B | $14.40B | $15.74 | $20.70B |
| 2023 | $371.62B | $90.96B | $32.36B | $22.38B | $24.22 | $25.68B |
| 2022 | $324.16B | $79.62B | $28.43B | $20.12B | $21.54 | $23.40B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
UNH is in 11 of the 30 ETFs we track. It weighs most in XLV: 5.45% of the fund, holding #5 of 62.
Famous investors who hold it
UNH is in the latest 13F of 2 of the 15 famous investors we follow. Chase Coleman (Tiger Global Management) holds the most of it: 0.52% of the portfolio, position #28 of 46, as of Q2 2026.
How it sits in healthcare
Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.
The companies it competes with
UNH beside the healthcare names it is usually measured against.
What the chart is saying
Slipped under its 50-day average inside a longer uptrend.
weakening- Price is 2.5% below its 50-day average and 6.1% above its 200-day.
- RSI at 49 is neither stretched nor washed out.
- The nearest ceiling is $384.18 (+1.3%), the nearest floor $359.57 (-5.2%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
Is UNH a good investment in 2026?
UnitedHealth Group trades at a P/E ratio of 24.4, with medium volatility (19.9% annualized). The stock is in a consolidation phase.
What is the risk level of UNH?
Based on 30-day volatility of 19.9%, UNH has MEDIUM risk. Beta of 0.61 indicates lower sensitivity to market movements than average.
Does UNH pay dividends?
Yes, UnitedHealth Group has a dividend yield of 2.45%.
How far is UNH from its all-time high?
UnitedHealth Group is 39.9% below its all-time high of $630.73, reached in November 2024. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +209.7%, against +312.9% for the S&P 500 (SPY).
Which ETFs hold UNH?
11 of the 30 popular ETFs we track hold UnitedHealth Group. The largest weights: XLV (5.45%), DIA (4.34%), SCHD (3.91%), VIG (1.51%) and VYM (1.41%). Measured on each issuer's full holdings file, dated August 31 to September 24, 2026.
How much of VOO is UNH?
0.53%, as of August 31, 2026: UNH is holding #31 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $5.34 in UnitedHealth Group.
Which famous investors own UNH?
Chase Coleman (0.52% of Tiger Global Management's 13F) and Renaissance Technologies (0.21% of Founded by Jim Simons's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for UNH?
The average analyst price target for UnitedHealth Group (UNH) is $480.60 based on 25 analyst estimates, about 26.7% above the current price of $379.30. The published range runs from $380.00 to $529.00.
How much revenue does UNH generate?
UnitedHealth Group reported $450.53B in trailing twelve-month revenue. Revenue growth is running at 0.4% year over year. Net margin sits at 3.1%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare UNH with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.